MedPath

Accelerometry at the Neck: Comparison With m. Adductor Pollicis Stimulation

Not Applicable
Completed
Conditions
Feasibility of Measurement of a Neuromuscular Block at the m. Trapezius
Interventions
Device: accelerometry m. trapezius and m. adductor pollicis
Registration Number
NCT01849198
Lead Sponsor
Kreiskrankenhaus Dormagen
Brief Summary

Accelerometric Assessment of neuromuscular block during anaesthesia is routinely performed at the M. adductor pollicis. However, many operations require positioning of the patients with arms attached to the body. In these situations, the anaesthesiologist has no access to the m.adductor pollicis.

In this study, a new position of accelerometry at the neck is evaluated: Stimulation of the n. accessorius with accelerometry of the m. trapezius.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Patients undergoing general anaesthesia with endotracheal intubation
  • weight 50-90 kg
Exclusion Criteria
  • Pregnancy
  • allergy to one of the drugs used
  • risk of pulmonary aspiration
  • expected difficulties with endotracheal intubation
  • intake of drugs known to influence neuromuscular block
  • infection (CRP > 0,5 mg/dl, leukocyte count > 12000/µl)

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Group trapeziusaccelerometry m. trapezius and m. adductor pollicisAssessment of intubation conditions after onset of the neuromuscular block at the m. trapezius
group adductor pollicisaccelerometry m. trapezius and m. adductor pollicisassessment of intubation conditions after onset of the neuromuscular block at the m. adductor pollicis
Primary Outcome Measures
NameTimeMethod
Recovery to a train of four ratio of 0.960 minutes

Comparison between time to recovery \[s\] to a train of four ratio of 0.9 between both groups

Secondary Outcome Measures
NameTimeMethod
onset of neuromuscular block10 min

Comparison of onset time \[s\] between both groups. Onset time is defined as decrease of T1 to \< 5% of initial twitch height.

Trial Locations

Locations (1)

KKH Dormagen

🇩🇪

Dormagen, Germany

KKH Dormagen
🇩🇪Dormagen, Germany
© Copyright 2025. All Rights Reserved by MedPath